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Every year, approximately 1 million new colorectal cancer
(CRC) cases are diagnosed and about half a million people
worldwide die due to this cancer. Known differences in CRC
incidence rates are mainly attributed to differences in diet
and other environmental factors represented, among others,
by nutrition-related complex diseases (e.g. obesity and
diabetes mellitus type II). Within the last years, it has become
evident that environmental risk factors can be complemented
by a genetic component when considering the risk of CRC.
For example, a number of polymorphisms are known to be
associated with an increased risk of obesity and obesity is
a risk factor for CRC. Several studies have shown that the
‘ancestral-susceptibility model’ can be reasonably applied to
nutrition-related complex diseases such as obesity. The work
in hand shortly discusses whether the ancestral-susceptibility
model can also be applied to CRC as a nutrition-related
complex disease.
Colorectal cancer epidemiology
Colorectal cancer (CRC) is one of the most common cancers
worldwide. The incidence rates for CRC vary among different
groups and populations depending on gender, age and country.
It is 1.2 times higher among males than among females and it
increases with age (1). It also varies 25-fold among different
populations worldwide. The highest incidence rates can be
found in New Zealand, Australia, North America, Western and
Northern Europe and more recently in Japan, while lower
incidence rates are reported from Africa, Asia and South
America (1–4). The differences in CRC incidence rates across
the globe are mainly attributed to differences in diet and other
environmental factors (3).
CRC—a nutrition-related complex disease
In 1994, Lander and Schork defined complex traits as follows:
‘The term ‘‘complex trait’’ refers to any phenotype that does
not exhibit classic Mendelian recessive or dominant inheritance
attributable to a single gene locus’ (5). Phenotypes of complex
diseases are due to multigenic or multifactorial influences.
A disease is called multigenic when more than one gene
alteration is required to develop the disease and multifactorial if
several genes and environmental factors contribute to risk of
developing a disease. The extent of the genetic and environ-
mental contribution to the risk of different diseases is highly
variable. In case of multifactorial disease, risk factors frequently
show additive effects. An example for a multigenic disease is the
Rhesus haemolytic disease, in which two Mendelian loci act
together to cause the disease phenotype. On the other hand, the
Hirschsprung disease is a well-described example for a multi-
factorial disease, in which several loci increase the susceptibility
to the disease but are not required for the development of the
phenotype (6). Multifactorial diseases, affected by both genetic
and non-genetic risk factors, are, for example, obesity, diabetes
mellitus type II (T2D), Alzheimer’s disease and also different
types of cancer, including CRC.
In comparison to the hereditary syndromes of CRC, the risk
for sporadic CRC can be highly affected by environmental risk
factors. Additionally, in the risk of CRC in familial CRC,
shared environmental factors play a prominent role. Up to now,
six major risk factors have been identified (7–9). Individuals
with a body mass index (BMI) 30 kg/m2 have a 40% higher
risk for CRC than individuals with a BMI 25 kg/m2 and the
risk of CRC is 20% higher among individuals affected with
diabetes compared to unaffected individuals. Additionally, in-
flammation, alcohol and read meat consumption, cigarette
smoking and low physical activity are among the most important
risk factors contributing to the risk of CRC (7–10). Next to these
most prominent risk factors, vitamin D consumption, calcium
intake, fruit and vegetable intake are also under discussion to
influence the risk of CRC (7,8).
Within the last years, it has become evident that environ-
mental risk factors themselves can be complemented by
a genetic component. In case of complex diseases like obesity
and T2D, the evidence is well defined and several poly-
morphisms are known to be associated with increased risk. But
also for risk factors, like cigarette smoking, recent studies have
identified genetic variants, influencing smoking behaviour and
nicotine dependence (11,12). Other polymorphisms are de-
scribed influencing the risk of CRC under the effect of
environmental factors (9). For example, different alleles of
CYP24A1 affect the CRC risk in association with vitamin D
and calcium intake, ultraviolet (UV) exposure and oestrogen
replacement therapy (9); a variant of CCND1 causes an early
onset in hereditary non-polyposis cancer but decreases the risk
of non-syndromic CRC in combination with oestrogen
exposure (13). Considering these interconnections, gene–
environment and gene–gene interactions strongly influence
the risk of CRC especially involving the complex diseases,
such as T2D and obesity, together with malnutrition and
supernutrition as key risk factors.
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Nutrition-related complex diseases, such as CRC, obesity and
T2D, are prominent diseases of humans living in industrialised
societies. This can be attributed to the circumstances that
modern societies provide an environment with almost un-
limited food supply combined with low energy expenditure
that are critical risk factors to CRC, obesity and T2D (2,8,14).
The environment provided by industrialised societies may
explain some of the high differences in CRC incidence rates
across the globe. In an evolutionary relevant timeframe of the
human evolution prior to industrialisation, conditions that re-
quired protective genetic variants against these diseases were
not widely spread. Hence, mechanisms to protect against super-
nutrition and its health consequences are so far rare either
because they have not yet evolved or because they are not yet
fixed in human populations (14). However, other features of
some of the known risk alleles provide evidence for an ongoing
adaptation, and signs of recent adaptation can be found in the
human genome (15). A distinct frequency decline from African
to European and East Asian populations can be detected for
several risk alleles. These frequency differences are getting
more pronounced with increasing geographical distance from
the ancestral African population (under the assumption of the
Out-of-Africa theory). Considering the significant changes of
the environmental conditions after leaving Africa 100 000
years ago, extreme changes in the frequency of the ancestral
alleles are an indicator that a selective process may have driven
the development of a gene due to a better adaptation to the new
environment (14,16,17). Altered requirements in modern and
ancestral environments or in geographically different environ-
ments may have reduced the advantage of the ancestral allele or
even made it harmful (18), while some derived alleles protect
against disease and become either neutral or advantageous
(19,20). This ‘ancestral-susceptibility model’ can be reasonably
applied to nutrition-related complex diseases (19).
The cultural evolution has changed the human diet funda-
mentally. According to several studies, the development of
agriculture and the domestication of animals have been by far
the most important cause of changes in human gene frequencies
in the past 10 000 years (14,19–22). Next to the introduction of
a variety of new pathogens to the human population, the dietary
focus shifted from wild animal protein and fat to domestic
animal fat; cereal grains, white flour and cane sugar replaced
fresh fruits and vegetables as primary sources of energy.
Consequently, the cultural evolution triggered several genetic
adaptations, such as the evolution of genetic resistance factors to
new crowd-sourced infectious diseases, the evolution of lactose
tolerance after ablactation and the evolution of adaptations to the
new dietary composition (14,19–22). Food allergies and
deficiencies related to animal milk and cereal diets reflect the
still incomplete human adaptation to these relatively new food
sources (14).
A well-known example for a relatively new adaptation in
human evolution is lactose tolerance (23). This trait developed
5000 years ago outside of Africa, when milk became also
available for ablactated children and adults due to the de-
velopment of agriculture. A new mutation evolved that allowed
individuals to digest milk even after ablactation. The ancestral
allele of this trait (being lactose intolerant), which had assured
that each new born child got enough aliment without rivalry by
older siblings, was no longer necessary and even became
harmful as milk became staple food. The new more useful gene
variant spread fast in those populations that developed agriculture,
and its frequency rose. However, the frequency differs consid-
erably among different worldwide populations. Accordingly, the
lactose intolerance trait underlies the ancestral-susceptibility
model (19).
In case of non-synonymous or coding polymorphisms like
lactose tolerance, it is relatively simple to describe the cause
and the direction of selective pressure due to the altered
function, while in case of non-coding or low-penetrance
polymorphisms, complex processes and interactions may cause
the final phenotype. Particularly in complex diseases, it should
be considered that the detected effect of a low-penetrance
polymorphism may affect an intermediate phenotype or that
selection had primarily worked on another trait than the
analysed one. Among others, possible triggers could be
pathogen stress (15,17,24–26) or UV irradiation (15,20,27).
Another trigger could be genetic hitchhiking. Genetic hitchhik-
ing describes the genetic linkage between a useful and
a harmful variant, whereby the effect of the useful variant is
more pronounced (28–32). By this process, selection could
have worked on the useful variant, ‘accepting’ the side effects
caused by the linked harmful variant. Additionally, it should be
considered that low-penetrance polymorphisms associated with
a complex disease can have relatively high frequencies in
a population. This might be due to different reasons. In case of
a disease that does not influence the reproductive success of an
individual, even high-risk alleles for a common disease can
spread in a population like neutral polymorphisms. Further-
more, highly variable allele frequencies in different populations
might be attributable to processes such as genetic drift or
founder effect that occur during the separation from the
ancestral population (33).
The expected inheritance model for ancestral-susceptibility
traits depends on the trait under consideration. In case of
lactose intolerance, the trait is considered recessive since it is
a monogenic trait with heterozygote individuals having 98%
enzyme activity, which does not influence their ability to digest
lactose, whereas homozygote carriers of the ancestral allele are
completely unable to digest lactose after infancy. In case of
skin colour adaptation or nutrition-related complex diseases,
such as CRC, T2D or obesity, which are multifactorial traits,
the expected inheritance model is more complicated, most
probably including both genetic and environmental factors.
Due to the fact that CRC is a nutrition-related disease that is
interlinked with obesity and T2D—both of which have been
demonstrated to underlie the ancestral-susceptibility model
(19)—it might be possible that CRC itself shows ancestral-
susceptibility risk alleles. Furthermore, it might be possible
that signs of ongoing selection can be found to alter CRC
susceptibility loci.
CTNNBL1 as an ancestral-susceptibility gene (example 1)
One example of a gene in which polymorphisms were found to
be associated not only with obesity and high BMI but also with
the risk of CRC is the CTNNBL1 gene [catenin (cadherin-
associated protein) b-like 1] (34–37). The study describing the
association of CTNNBL1 with the risk of CRC and fulfilling the
characteristics of the ancestral-susceptibility model is shortly
reviewed in the following (34).
For the association study, two separate case–control study
populations were used. First, a hospital-based study population
that originated from the Czech Republic was analysed (38).











This population contained sporadic CRC incident cases and
healthy controls. Second, a family-based study population
originated from Germany was used (39,40). This population
contained case samples with family history of CRC or early
onset of CRC and blood donor control samples. From all study
participants, DNA has been extracted from peripheral leuko-
cytes by the executive departments in the Czech Republic
and Germany. Based on an optimal ratio of directly genotyped
versus captured single-nucleotide polymorphisms (SNPs)
(r2  0.8), eight unlinked intronic tagSNPs with a minor allele
frequency 5% were selected (rs6067377, rs2344481,
rs238302, rs2281148, rs2235460, rs6067889, rs4811233 and
rs6067923) for genotyping. These tagSNPs represent a total of
123 SNPs annotated in the NCBI dbSNP (http://www.
ncbi.nlm.nih.gov) encompassing the whole gene. Thus, the
SNPs were expected to give information of all common genetic
variation within the gene region. The genotype analyses in
CTNNBL1 were performed using allele-specific polymerase
chain reaction-based TaqMan assays, designed by Applied
Biosystems (TaqMan SNP Genotyping Assays; Human
Pre-Designed Assays Applied Biosystems, Weiterstadt,
Germany).
Of the eight selected tagSNPs, three were found to be
associated with the risk of CRC. In particular, rs2344481 and
rs2235460 showed a modest association of the ancestral allele
with an increased risk of CRC in the Czech population and in
the analysis of the joint populations (Figure 1). The ancestral
allele of rs2281148 showed the opposite effect.
To characterise the gene, phylogenetic networks were
applied to the sequence of CTNNBL1 and the recombination
rate and regulatory potential were analysed using UCSC
Genome Browser on Human [Mar. 2006 Assembly (hg18)
(http://genome.ucsc.edu/) (12,41,42)].
The phylogenetic analysis of the DNA sequences of
CTNNBL1 provided insight about the interspecific conservation
of the analysed gene region. The algorithm resulted in highly
resolved phylogenetic trees that reflected one of the today’s
valid phylogenetic trees of animals (43). One tree was based on
the complementary DNA (cDNA) sequence of CTNNBL1;
other trees were based on intronic sequences (Figure 2). The
analysis showed that the intron-based phylogenetic trees
resembled the cDNA tree in many points. In Figure 2, the
phylogenetic tree of intron 3 is shown as an example. The order
and species clades were equally well dissolved in the intronic
tree as in the cDNA tree. In the case of the primates clade, it
fitted the today’s valid phylogenetic tree even better than the
cDNA tree. Both trees failed in resolving the Laurasiatheria
and Euarchontoglires clade (43).
The analysis of the gender-based recombination rate
revealed huge differences between males and females. The
female recombination rate in CTNNBL1 was found to be
significantly higher than the male one (3.86 times). Addition-
ally, the female recombination rate exceeded that of the gene
region and the average chromosomal rate (1.6 and 1.5 times,
respectively) (Figure 3B). The regulatory potential in
CTNNBL1 was estimated with 0.06, generally ranging from
0.0 (low) to 0.1 (high).
To characterise the three polymorphisms in CTNNBL1 that
showed a significant association with CRC and to detect
possible signs of selection, global allele frequencies, the
fixation indexes (FST) (47), the site-by-site frequency spectrum
test of Fay-Wu’s H (20,29) and the haplotype test for
Standardised integrated haplotype score (iHS) (20,48) were
analysed in the Caucasian population (CEU, Utah residents
with Northern and Western European ancestry from the CEPH
collection), the Sub-Saharan African population (YRI, Yoruba
in Ibadan, Nigeria) and the East Asian population (HCB, Han
Chinese in Beijing, China, and JPT, Japanese in Tokyo, Japan).
The three SNPs showed high worldwide allele frequency
differences (.45%; YRI versus CEU versus HCB/JPT);
rs606737 and rs2344481 also showed high allele frequency
differences between YRI and CEU population (53.5 and 46.5%),
respectively, with the ancestral allele frequency changing from
the major to the minor allele from YRI to non-African
populations. Based on the allele frequency data of the genotyped
polymorphisms, the fixation indexes (FST)) and the correspond-
ing probability values were estimated using the Arlequin 3.1
Software (47) (Figure 3A). The FST is a measure of genetic
differences among subpopulations, population differentiation
and genetic distance: FST values .0.25 indicate strong genetic
differentiation (i.e. the SNPs might have been targets of
selection); FST values in the range of 0.05–0.1 indicate moderate
genetic differentiation (15). FST P values 0.05 are generally
considered to be evolutionarily significant (49). In CTNNBL1,
the FST statistics indicated strong genetic differentiation for the
polymorphisms rs2344481 and rs2281148 (FST . 0.25), when
the allele frequencies of the African population were compared
with the allele frequencies of non-African populations. A mod-
erate genetic differentiation was also found in the comparison of
European versus Chinese for rs2344481 and rs2281148. For
Fig. 1. Data plot of the odds ratios (ORs) and 95% confidence intervals (CIs)
of three SNPs in CTNNBL1 that were found to be significantly associated with
the risk of CRC in the Czech cohort. Comparison of the individual results of
the Czech and the German cohort (dominant model, unadjusted data) and the
results of the joint analysis (dominant model, adjusted for age, gender and
nationality). Rhombus OR; bars 95% CI; CZ, Czech samples; G, German
samples.











rs2235460, moderate genetic differentiation (FST 5 0.05) was
shown, in a comparison of African and Japanese population as
well as Chinese and Japanese population. All estimates that
indicated strong or moderate differentiation showed statistical
significance at the 5% level, signalling evolutionary significance
(15,49).
Fig. 2. Phylogenetic trees of the cDNA sequence and intronic DNA (intron 3) sequence of CTNNBL1 (34). Different taxa are represented by nodes and their
evolutionary relationships are represented by branches. Bootstrap values indicate how reliable a clade is. All tested introns gave similar phylogenetic trees as intron
3, exemplarily shown here. Phylogenetic trees of the cDNA sequences and intronic DNA sequences of different species were created with the program SplitsTree
V4.10 (44). The sequences of Homo sapiens sapiens, Pan troglodytes, Pongo pygmaeus, Macaca mulatta, Mus musculus, Rattus norvegicus, Bos taurus, Equus
freus caballus, Canis lupus familiaris and Monodelphis domestica gained from the Ensembl Genome Browser [http://www.ensembl.org/index.html; Hubbard et al.
(45)] were aligned using MEGA4 software (46). For the cDNA, the sequence of Gallus gallus domesticus was additionally used for alignment. The sequence
alignments were utilised to calculate phylogenetic consensus trees using the neighbour joining method and to calculate bootstrap values (SplitsTree V4.10) [Huhn et al.
(34); figure modified and reprinted by permission of Copyright Office e-Century Publishing Corporation; 2011].
Fig. 3. (A) FST for CRC-associated SNPs in CTNNBL1 comparing European (CEU), Chinese (HCB), Japanese (JPT) and African (YRI) population. Matrix of
pairwise FST; z indicates strong genetic differentiation and * indicates moderate genetic differentiation at 5% statistical significance. (B) Plot of the recombination
rate estimated for CTNNBL1 gene in comparison to the local and average chromosomal rate. (C) Plot of the Standardised jiHSj estimate and (D) of Fay-Wu’s H
estimate for rs6020395 in CTNNBL1. Rs6020395 was linked to the genotyped SNP rs2344481 (r2 . 0.8). Comparison of the African (YRI), European (CEU) and
East Asian (ANS) population.











All estimates of Fay-Wu’s H and iHS refer to SNPs that are
linked to the genotyped SNPs (r2 . 0.8), due to the fact that
direct values of Fay-Wu’s H and iHS of the genotyped SNPs
were not available in the Haplotter web application (http://
haplotter.uchicago.edu/) (20). Strong negative Fay-Wu’s H was
considered as signatures for a selective sweep (20,29). iHS ,
1.5 and . 1.5 give conclusive evidence for natural selection
and iHS , 2 or . 2 give evidence for a powerful selection
signal (20,48). Signatures of a selective sweep and conclusive
evidence for natural selection were found in CTNNBL1 SNP
rs6020395 (Fay-Wu’s H 5 25.79; jiHSj 5 1.63) (Figure 3C
and D). This SNP was linked to the genotyped SNP rs2344481
(r2 . 0.8).
These results suggest that the ancestral-susceptibility model
may apply to SNPs in CTNNBL1 and risk of CRC.
Additionally, previous studies in CTNNBL1 indicated an
association of polymorphisms within this gene with an
increased risk of obesity and increased BMI and fat mass
(35–37). The described associations were also conferred by the
ancestral alleles of the SNPs analysed in these studies
Table I. Information about genes and SNPs associated with obesity and BMI and possible other nutrition-related traits
Nearest gene rs No. Chr. Position SNP (A/D) Risk on A or D Associated diseases Function or location Reference
NEGR1 rs3101336 01p31.01 72.524.023 A/G D BMI NERG1 3 kb
upstream
(54)
NEGR1 rs2568958 01p31.01 72.537.954 G/A D BMI NERG1 17 kb
upstream
(54)





SEC16B rs10913469 01q25.02 176.180.392 C/T A BMI Intron (54)
TMEM18 rs2867125 02p24.03 613.077 G/A A BMI TMEM18 45 kb
downstream
(54)





TMEM18 rs4854344 02p24.03 628.394 G/T D BMI TMEM18 30 kb
downstream
(54)
TMEM18 rs7561317 02p24.03 635.203 A/G D BMI TMEM18 23 kb
downstream
(56)
INSIG2 rs7566605 02q14.01 118.552.745 G/C D Obesity INSIG2 10 kb
downstream
(57)
CCDC93 rs11684454 02q14.01 118 479 788 A/G D Obesity Intron (48)
ETV5;
DGKG









PCSK1 rs6235 05q15.00 95.754.904 G/C D BMI, obesity,
T2D
Missense (19,58,59)
PCSK1 rs6232 05q15.00 95.777.791 A/G D BMI, obesity,
T2D
Missense (58,59)
ADRB2 rs1042714 05q33.01 148.186.916 G/C A Obesity, asthma Missense (19)
PRL rs4712652 06p22.03 22.186.844 A/G A BMI PRL 208 kb
upstream
(60)
MTMR9 rs2293855 08p23.01 11.215.070 G/A A Obesity Intron (61)
ADRB3 rs4994 08q12.00 37.943.205 C/T A BMI, obesity,
T2D
Missense (19)
GAD2 rs2236418 10p12.01 26.545.752 G/A A Obesity 5# UTR (19)
GAD2 rs992990 10p12.01 26.226.611 A/C A Weight gain,
eating behaviour
Intron (62)
GAD2 rs7908975 10p12.01 26.173.635 C/A A Weight gain,
eating behaviour
Intron (62)
PTER rs10508503 10p13.00 16.340.207 C/T A BMI PTER 179 kb
downstream
(60)
PFPK rs6602024 10p15.02 3.145.487 G/A D BMI Intron (63)
MTCH2 rs4752856 11p11.02 47.604.868 G/A D BMI, obesity,
T2D
Intron (55)
MTCH2 rs10838738 11p11.02 47.619.875 A/G D BMI Intron (64)
BDNF;
BDNFOS

































[rs16986921, rs6020712, rs6013029, odds ratios  1.3]. All
three analysed SNPs are in high linkage disequilibrium (r2 
0.85) with the SNP rs2344481 that showed the most significant
association with CRC (34). By this, CTNNBL1 showed shared
ancestral susceptibility to CRC and obesity.
CTNNBL1 was suggested as a putative regulator of the
canonical Wnt signalling pathway, acting upstream of or in
parallel to, b-catenin (34,35). This pathway, if altered or
disrupted due to mutations within its components, is known to
be related to the development of CRC and other types of cancer
(50,51). Furthermore, the Wnt signalling pathway was also
shown to be connected to nutrition-related traits, such as
normal cholesterol metabolism and glucose-induced insulin
secretion and polymorphisms in Wnt signalling components
were found to be associated with obesity and T2D (50,52,53).
Other obesity-associated genes following the ancestral-
susceptibility model (example 2)
The findings in CTNNBL1 encouraged the idea to search for
other nutrition-associated polymorphisms that also show
ancestral susceptibility to a nutrition-related disease and test
them for a possible association with CRC. The PubMed database
was browsed for genome-wide association studies that focused
on obesity or BMI. In 18 publications, 53 polymorphisms were
found to be associated with obesity or BMI (Table I).
Of them, 29 SNPs showed ancestral susceptibility and out of
them, 9 showed high allele frequency differences (.45%)
between African and non-African population as a first indicator
of selective pressure. In a first trial, polymorphisms within four
of those genes [MTMR9 (61) (two SNPs), GAD2 (19,62) (five
SNPs), BBS4 (58) (one SNP) and NPC1 (60) (one SNP)] were
selected to be analysed in an association study in the Czech
case–control sample population described in ref. (38). All
selected genes encode proteins that have been linked to food
intake and obesity, thus being good candidates for CRC
susceptibility genes.
The myotubularin-related protein 9 (MTMR9) is located at
chromosome 8p23–p22. The encoded inactive phosphatase-
like molecule interacts with active phosphatases members
of the myotubularin-related protein family (MTMR7 and
MTMR6). Several original research reports describe a linkage
between this locus and obese phenotypes (61,70). MTMR9
expression in the lateral hypothalamic area, the paraventricular-
and arcuate-nucleus of the hypothalamus was found to be
regulated by diet, especially high-fat diet and might be
Table 1. Continued
Nearest gene rs No. Chr. Position SNP (A/D) Risk on A or D Associated diseases Function or location Reference
BDNF;
BDNFOS
rs6265 11p14.01 27 636 742 G/A A BMI Missense in BNDF (54)
BCDIN3D rs7138803 12q13.13 48.533.985 G/A D BMI FAIM2 13 kb;
BCDIN3D 10 kb
(54)
NRXN3 rs10146997 14q31.01 79.015.165 G/A A BMI, waist to
hip ratio
Intron (65)









SH2B1 rs4788102 16p11.02 28.781.149 G/A D BMI SH2B1 1.4 kb
downstream
(54)
SH2B1 rs7498665 16p11.02 28.790.992 G/A A BMI, obesity,
T2D
Missense (55)
FTO rs6499640 16q12.02 52.327.428 A/G A BMI Intron (54)
FTO rs9939973 16q12.02 52.358.319 G/A D Obesity Intron (66)
FTO rs1421085 16q12.02 52.358.705 T/C D BMI Intron (60)
FTO rs1121980 16q12.02 52.366.998 T/C A BMI, obesity,
T2D
Intron (55,66)
FTO rs8050136 16q12.02 52.374.026 A/C A BMI Intron (54)
FTO rs8050136 16q12.02 52.374.026 A/C A T2D, BMI Intron (48,67,68)
FTO rs3751812 16q12.02 52.376.211 G/T D BMI Intron (54)
FTO rs9939609 16q12.02 52.377.778 A/T A BMI Intron (67)
FTO rs9939609 16q12.02 52.378.278 A/T A T2D, BMI Intron (69)
FTO rs7190492 16q12.02 52.386.503 G/A A BMI Intron (54)
FTO rs9930506 16q12.02 52.388.216 G/A A BMI, hip, weight Intron (63)
FTO rs8044769 16q12.02 52.396.886 C/T A BMI Intron (54)
NPC1 rs1805081 18q11.02 19.394.680 A/G A BMI Missense (60)
MC4R rs17782313 18q21.32 56.002.327 T/C D BMI MC4R 187 kb
downstream
(60)
MC4R rs12970134 18q21.32 56.035.980 G/A D BMI, T2D MC4R 53 kb
downstream
(54)
KCTD15 rs29941 19q13.11 39.001.622 C/T A BMI KCTD15 6 kb
upstream
(54)





CTNNBL1 rs16986921 20q11.23 33117843 T/C A BMI, fat mass, obesity Intron (35–37)
CTNNBL1 rs6020712 20q11.23 33121934 A/G A BMI, fat mass, obesity Intron (35–37)
CTNNBL1 rs6013029 20q11.23 33134902 T/G A BMI, fat mass, obesity Intron (35–37)
Chr, chromosome; A, ancestral allele, D, derived allele.











involved in appetite regulation (61). The glutamate decarbox-
ylase 2 (GAD2) gene encodes for the glutamic acid
decarboxylase enzyme (GAD65), which is thought to regulate
synaptic release of c-aminobutyric acid (GABA). The GABA
neurotransmitter in the brain impacts most neural functions and
is involved in the regulation of food intake (62). The Bardet-
Biedl syndrome 4 (BBS4) gene is a member of the BBS gene
family. BBS is an autosomal recessive disorder characterised
by rod–cone dystrophy, postaxial polydactyly, central obesity,
mental retardation, hypogonadism and renal dysfunction (71).
BBS proteins were described to be localised to primary cilia
(72). The Niemann-Pick disease type C1 (NPC1) gene encodes
a protein that mediates intracellular cholesterol trafficking.
Mutations in NPC1 and also NPC2 genes characterise manifest
as Niemann-Pick disease, which is a rare, usually fatal,
autosomal recessive, lysosomal storage disorder (73).
None of the tested SNPs showed statistically significant
associations with CRC (P values ranging from 0.21 to 0.79;
dominant model; data adjusted for age and gender). However,
combining these recent results with those previously described
in the Example 1 (CTNNBL1), one of five obesity-associated
genes showed ancestral susceptibility to CRC and to obesity.
Further studies on genes showing ancestral susceptibility to
other nutrition-related diseases, such as T2D, cholesterol
levels, hypertension and metabolic syndrome, are planned.
The fact that all analysed SNPs were non-coding SNPs does
not negate the hypothesis. Several functional non-protein-
coding DNA sequences, such as cis-regulatory sequences (74)
and microRNAs (75), are known to be targets of selection.
Polymorphisms associated with multifactorial traits are often
located in non-coding sequences, such as in regulatory
sequences, 3# untranslated regions, introns or intergenic
sequences of unknown transcriptional status (76). Especially,
the new discoveries in the field of epigenetics highlight the role
of non-coding DNA sequences in regulatory processes and
associations of polymorphisms in these regions with complex
diseases (76). It should also be considered that the detected
SNP may be linked to a still unknown functional variant as the
actual target of selection or that the SNP itself may have a so
far unknown regulatory function.
Future perspectives
Due to their complexity, nutrition-related traits and their
consequences, intertwining several environmental factors and
so far unknown number of genetic variants are great challenges
for medical science, disease prevention, therapy and health care
policy. A better understanding of the extent of the influence of
these factors on the individual risk or on the risk of a population
might make it possible to improve prevention, prognosis and
treatment. Since susceptibility variants were suggested to show
additive effects not only to the risk of cancer but also to the risk
of nutrition-related diseases, also variants showing modest
effects might be of interest for closer investigation (9). The
presented examples suggest that genes found to be associated
with one nutrition-related disease might also be promising
candidates for other related diseases. The application of
additional selection criteria, such as ancestral susceptibility,
global allele frequency differences, pathway membership or
signatures of selection, might help to narrow down the numerous
published polymorphisms and mutations to find the most
promising candidates to test in case–control association studies.
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